Smith & Nephew SNATS, Inc. (SNN) vs Zimmer Biomet Holdings, Inc. (ZBH)
Smith & Nephew SNATS, Inc. and Zimmer Biomet Holdings, Inc. are both Medical Devices companies. Zimmer Biomet Holdings, Inc. is the larger, with a market value of $17.1B against $11.2B — 1.5× the size. Zimmer Biomet Holdings, Inc. trades at the lower P/E: 22.0× against 32.8×. Zimmer Biomet Holdings, Inc. grew revenue faster over the last twelve months: 8.62% against 4.81%. Zimmer Biomet Holdings, Inc. has the higher net margin (9.48% vs 6.71%) and the higher return on invested capital (3.82% vs 0.00%). Both pay a dividend; Smith & Nephew SNATS, Inc. yields more (2.67% vs 0.69%). Across the 23 metrics below, Smith & Nephew SNATS, Inc. leads on 12 and Zimmer Biomet Holdings, Inc. on 11.
Valuation
Profitability
| Metric | SNN | ZBH | Medical Devices median |
|---|---|---|---|
| Gross margin | 70.52% | 69.87% | 56.01% |
| Operating margin | 0.00% | 14.16% | (15.03%) |
| Net margin | 6.71% | 9.48% | (20.40%) |
| Free cash flow margin | 0.00% | 12.18% | (7.24%) |
| Return on equity | 0.00% | 6.41% | (15.32%) |
| Return on assets | 0.00% | 3.53% | (19.72%) |
| Return on invested capital | 0.00% | 3.82% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack